Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study

Cancer Imaging

Jin Seok Ahn¹  Jong-Mu Sun¹  Myung-Ju Ahn¹  Kyung Soo Lee²  Ho Yun Lee²  Keunchil Park¹ 

[1]Division of Hemato-Oncology of the Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDivision of Hemato-Oncology of the Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDivision of Hemato-Oncology of the Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

[2]Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South KoreaDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

关键词: Tumor volume;    Biomarkers;    Prognosis;    Growth kinetics;    Quantitative analysis;   

DOI  :  10.1186/s40644-016-0063-7

来源: e-MED Ltd

【 授权许可】

Unknown